标题/作者	年份
External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry A Boucly, J Weatherald, L Savale, P De Groote, V Cottin, G Prévot, ... European Respiratory Journal 59 (6)	2022
Interstitial lung diseases M Wijsenbeek, A Suzuki, TM Maher The Lancet 400 (10354), 769-786	2022
Sustained effectiveness of elexacaftor-tezacaftor-ivacaftor in lung transplant candidates with cystic fibrosis C Martin, M Reynaud-Gaubert, R Hamidfar, I Durieu, M Murris-Espin, ... Journal of Cystic Fibrosis 21 (3), 489-496	2022
Lung transplantation for interstitial lung disease SG Kapnadak, G Raghu European Respiratory Review 30 (161)	2021
Diagnosis, course and management of hypersensitivity pneumonitis M Hamblin, H Prosch, M Vašáková European Respiratory Review 31 (163)	2022
Putting ethics and clinical decision making before politics: requiring COVID-19 immunization for Solid Organ Transplantation (SOT) Candidates and their Support Team M Kuczewski, K Wasson, PJ Hutchison, DF Dilling The Journal of Heart and Lung Transplantation 41 (1), 17-19	2022
Group 3 pulmonary hypertension: from bench to bedside N Singh, P Dorfmüller, OA Shlobin, CE Ventetuolo Circulation Research 130 (9), 1404-1422	2022
Race and ethnicity in pulmonary function test interpretation: an official American Thoracic Society Statement NR Bhakta, C Bime, DA Kaminsky, MC McCormack, N Thakur, ... American Journal of Respiratory and Critical Care Medicine 207 (8), 978-995	2023
Full recovery of right ventricular systolic function in children undergoing bilateral lung transplantation for severe PAH G Hansmann, F Diekmann, P Chouvarine, F Ius, J Carlens, N Schwerk, ... The Journal of Heart and Lung Transplantation 41 (2), 187-198	2022
The changing landscape of pediatric lung transplantation N Avdimiretz, C Benden Clinical Transplantation 36 (4), e14634	2022
A focused review on primary graft dysfunction after clinical lung transplantation: a multilevel syndrome J Van Slambrouck, D Van Raemdonck, R Vos, C Vanluyten, A Vanstapel, ... Cells 11 (4), 745	2022
Sporadic lymphangioleiomyomatosis: treatment and prognosis FX McCormack, N Gupta, P Dieffenbach UpToDate	2020
Low body mass index as a barrier to lung transplant in cystic fibrosis AL Jennerich, JB Pryor, TYH Wai, SG Kapnadak, ML Aitken, CH Goss, ... Journal of Cystic Fibrosis 21 (3), 475-481	2022
Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative—Group 3 pulmonary hypertension SM Nikkho, MJ Richter, E Shen, SH Abman, K Antoniou, J Chung, ... Pulmonary Circulation 12 (3), e12127	2022
Expected effect of the lung Composite Allocation Score system on US lung transplantation M Valapour, CJ Lehr, A Wey, MA Skeans, J Miller, ED Lease American Journal of Transplantation 22 (12), 2971-2980	2022
Impact of incorporating long-term survival for calculating transplant benefit in the US lung transplant allocation system CJ Lehr, A Wey, MA Skeans, ED Lease, M Valapour The Journal of Heart and Lung Transplantation 41 (7), 866-873	2022
Idiopathic pulmonary fibrosis: state of the art for 2023 AJ Podolanczuk, CC Thomson, M Remy-Jardin, L Richeldi, FJ Martinez, ... European Respiratory Journal 61 (4)	2023
Towards biohybrid lung development—fibronectin-coating bestows hemocompatibility of gas exchange hollow fiber membranes by improving flow-resistant endothelialization M Pflaum, S Jurmann, K Katsirntaki, M Mälzer, A Haverich, B Wiegmann Membranes 12 (1), 35	2021
A center experience with lung transplantation for COVID-19 ARDS DJ Franco-Palacios, L Allenspach, L Stagner, J Pinto, K Olexsey, ... Respiratory Medicine Case Reports 36, 101597	2022
Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantation H Vicaire, J Le Pavec, O Mercier, D Montani, A Boucly, A Roche, ... The Journal of Heart and Lung Transplantation 41 (9), 1285-1293	2022

1 - 20

计算机程序会自动估算并确定日期和引用次数。